How Effective Is Endovascular Intracranial Revascularization in Stroke Prevention? Results from Borgess Medical Center Intracranial Revascularization Registry

References

1. 1.↵
   1. Chimowitz MI,
   2. Lynn MJ,
   3. Howlett-Smith H,
   4. et al

   . for the Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305–16

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Fisher CM,
   2. Gore I,
   3. Okabe N,
   4. et al

   . Atherosclerosis of the carotid and vertebral arteries: extracranial and intracranial. J Neuropath Exp Neurol 1965;24:455–76

   CrossRefWeb of Science
3. 3.↵
   1. Gupta R,
   2. Schumacher HC,
   3. Mangla S,
   4. et al

   . Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis. Neurology 2003;61:1729–35

   Abstract/FREE Full Text
4. 4.↵
   1. Lylyk P,
   2. Cohen JE,
   3. Ceratto R,
   4. et al

   . Angioplasty and stent placement in intracranial atherosclerotic stenosis and dissections. AJNR Am J Neuroradiol 2002;23:430–36

   Abstract/FREE Full Text
5. 5.↵
   1. Marks MP,
   2. Marcellus ML,
   3. Do HM,
   4. et al

   . Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. AJNR Am J Neuroradiol 2005;26:525–30

   Abstract/FREE Full Text
6. 6.↵
   1. du Mesnil de Rochemont R,
   2. Turowski B,
   3. Buchkremer M,
   4. et al

   . Recurrent symptomatic high-grade intracranial stenosis: safety and efficacy of undersized stents—initial experience. Radiology 2004;231:45–49

   PubMedWeb of Science
7. 7.↵
   1. Mori T,
   2. Fukuoka M,
   3. Kazita K,
   4. et al

   . Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuradiol 1998;19:1525–33

   Abstract
8. 8.↵
   1. Samuels OB,
   2. Joseph GJ,
   3. Lynn MJ,
   4. et al

   . A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 2000;21:643–46

   Abstract/FREE Full Text
9. 9.↵
   1. Yoon W,
   2. Seo JJ,
   3. Cho KH,
   4. et al

   . Symptomatic middle cerebral artery stenosis treated with intracranial angioplasty: experience in 32 patients. Radiology 2005;237:620–26

   PubMedWeb of Science
10. 10.↵
    1. Bose A,
    2. Hartmann M,
    3. Henkes H,
    4. et al

    . A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenosis: the Wingspan study. Stroke 2007;38:1531–37

    Abstract/FREE Full Text
11. 11.↵
    1. Chaturvedi S,
    2. Turan TN,
    3. Lynn MJ,
    4. et al

    . for the WASID Study Group. Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology 2007;69:2063–68

    Abstract/FREE Full Text
12. 12.↵
    1. Fiorella DJ,
    2. Levy EI,
    3. Turk AS,
    4. et al

    . US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 2007;38:881–87

    Abstract/FREE Full Text
13. 13.↵
    1. Fiorella DJ,
    2. Levy EI,
    3. Turk AS,
    4. et al

    . Target lesion revascularization after Wingspan: assessment of safety and durability. Stroke 2009;40:106–10

    Abstract/FREE Full Text
14. 14.↵
    1. Gröschel K,
    2. Schnaudigel S,
    3. Pilgram SM,
    4. et al

    . A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke 2009;40:e340–47

    Abstract/FREE Full Text
15. 15.↵
    1. Gupta R,
    2. Al-Ali F,
    3. Thomas AJ,
    4. et al

    . Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke 2006;37:2562–66

    Abstract/FREE Full Text
16. 16.↵
    1. Kallmes DF,
    2. Cloft HJ

    . How do we spin Wingspan? AJNR Am J Neuroradiol 2008;29:28–29

    FREE Full Text
17. 17.↵
    1. Kern R,
    2. Steinke W,
    3. Daffertshofer M,
    4. et al

    . Stroke recurrences in patients with symptomatic vs asymptomatic middle cerebral artery disease. Neurology 2005;65:859–64

    Abstract/FREE Full Text
18. 18.↵
    1. Kurre W,
    2. Berkefeld J,
    3. Sitzer M,
    4. et al

    . Treatment of symptomatic high-grade intracranial stenoses with the balloon-expandable Pharos stent: initial experience. Neuroradiology 2008;50:701–08

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Levy EI,
    2. Hopkins LN,
    3. Turk AS,
    4. et al

    . Response to the commentary “How do we spin Wingspan?” AJNR Am J Neuroradiol. 2008;29:e67–e68

    FREE Full Text
20. 20.↵
    1. Marks MP,
    2. Wojak JC,
    3. Al-Ali F,
    4. et al

    . Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke 2006;37:1016–20

    Abstract/FREE Full Text
21. 21.↵
    1. Mazighi M,
    2. Yadav JS,
    3. Abou-Chebl A

    . Durability of endovascular therapy for symptomatic intracranial atherosclerosis. Stroke 2008;39:1766–69

    Abstract/FREE Full Text
22. 22.↵
    1. Siddiq F,
    2. Vazquez G,
    3. Memon MZ,
    4. et al

    . Comparison of primary angioplasty with stent placement for treating symptomatic intracranial atherosclerotic diseases: a multicenter study. Stroke 2008;39:2505–10

    Abstract/FREE Full Text
23. 23.↵
    1. Turan TN,
    2. Chimowitz MI

    . Treatment of intracranial atherosclerotic stenosis. Rev Neurol Dis 2008;5:117–24

    PubMed
24. 24.↵
    1. Turan TN,
    2. Derdeyn CP,
    3. Fiorella D,
    4. et al

    . Treatment of atherosclerotic intracranial arterial stenosis. Stroke 2009;40:2257–61

    FREE Full Text
25. 25.↵
    1. Zaidat OO,
    2. Klucznik R,
    3. Alexander MJ,
    4. et al

    . for the NIH Multi-Center Wingspan Intracranial Stent Registry Study Group. The NIH registry of use of the Wingspan stent for symptomatic 70–99% intracranial arterial stenosis. Neurology 2008;70:1518–24. Epub 2008 Jan 30

    Abstract/FREE Full Text
26. 26.↵
    1. Al-Ali F,
    2. Cree T,
    3. Hall S,
    4. et al

    . Predictors of unfavorable outcomes in intracranial angioplasty and stenting. AJNR Am J Neuroradiol. In press
27. 27.↵
    1. Kasner S,
    2. Chimowitz M,
    3. Lynn M,
    4. et al

    . for the Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006;113:555–63

    Abstract/FREE Full Text
28. 28.↵
    SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004;35:1388–92. Epub 2004 Apr 22

    Abstract/FREE Full Text